Using MRI to assess penile cancer before surgery
The Role of Functional Magnetic Resonance Imaging in Preoperative Assessment of Primary Penile Carcinoma
Oslo University Hospital · NCT05447273
This study is testing whether a special type of MRI can help doctors better plan surgery for men with newly diagnosed penile cancer to improve their quality of life and reduce the chance of the cancer coming back.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Sex | Male |
| Sponsor | Oslo University Hospital (other) |
| Locations | 1 site (Oslo) |
| Trial ID | NCT05447273 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of multi-parametric magnetic resonance imaging (mpMRI) in the preoperative assessment of patients with newly diagnosed penile squamous cell carcinoma (SCC). The study will include 60 patients referred to Oslo University Hospital for organ-sparing surgery (OSS), which may enhance quality of life and sexual function. By utilizing mpMRI, the researchers hope to improve patient selection and reduce the risk of local recurrence after surgery. The non-invasive nature of this imaging technique makes it a comfortable option for patients.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with newly diagnosed penile squamous cell carcinoma who are suitable for organ-sparing surgery.
Not a fit: Patients who do not have penile squamous cell carcinoma or those who are not candidates for organ-sparing surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to better surgical outcomes and improved quality of life for patients with penile cancer.
How similar studies have performed: While the use of mpMRI in this context is promising, it is not yet widely incorporated into clinical practice, indicating that this approach may be novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * newly diagnosed penile squamous cell carcinoma (SCC) * the patient will benefit from organ-sparing surgery (OSS) * signed broad consent for cancer research Exclusion Criteria: * N/A
Where this trial is running
Oslo
- Oslo University Hospital — Oslo, Norway (RECRUITING)
Study contacts
- Principal investigator: Marta D Switlyk, MD PhD — Oslo University Hospital
- Study coordinator: Marta D Switlyk, MD PhD
- Email: marswi@ous-hf.no
- Phone: 47 915 02 770
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Penile Cancer